Search Results 291-300 of 17174 for Albicans

  1. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...

  2. Division of Clinical Microbiology - Laboratory Medicine and Pathology

    Mayo enterprise laboratories have developed and implemented culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods to ...

  3. (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive - Mayo Clinic

    (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive. Print ...

  4. Immune-mediated adverse events - Mayo Clinic

    CT chest scan, PET-CT scan and transbronchoscopic biopsy indicating immune-mediated adverse events. Share · Tweet . IMG-20400457.

  5. Treatment

    Cutaneous B-cell lymphoma treatment depends on the specific type of lymphoma that you have. Treatment options may include: Radiation therapy.

  6. Publications - Daniel F. Labuz - Mayo Clinic

    Whitlock AE, Moskowitzova K, Labuz DF, Sewall N, Mullin K, Kycia I, Zurakowski D, Fauza DO. Fetal Secretory IgA Delivery via Transamniotic Fetal ...

  7. Mayo Clinic

    Fuel groundbreaking medical research! ... Your donation powers the future of medicine and helps save lives. Give Today.

  8. Burkitt lymphoma - Doctors and departments - Mayo Clinic

    Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.

  9. Vulvar cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that forms on the skin that surrounds the urethra and vagina. Treatments include surgery, radiation and chemotherapy.

  10. A Study Of CSF-1R Inhibitor, AXatilimab For GVHD After HLA-matched Related And Unrelated Donor Allogeneic Stem Cell Transplantation (ABRAXAS) - Mayo Clinic

    About this study. This study will determine if axatilimab in combination with standard of care posttransplant cyclophosphamide+ tacrolimus/mycophenolate ...